Sign In
Buy PCVX
$51.96
-0.150 (-0.288%)
At Close: Jun 23, 2026
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
04:15pm, Thursday, 12'th Nov 2020
FOSTER CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel va
Vaxcyte to Present at Jefferies Virtual London Healthcare Conference
04:41pm, Tuesday, 10'th Nov 2020
FOSTER CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel va
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
Dow Jones Edges Higher In New Bid For 28,000; Tesla, AMAT Stock Lead Nasdaq
07:01pm, Friday, 14'th Aug 2020
The Dow Jones held a modest gain late Friday, buoyed by a 2% gain for Boeing stock. A strong earnings report lifted AMAT stock in the Nasdaq 100.
CORRECTION – Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
08:59pm, Wednesday, 12'th Aug 2020
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Vaxcyte, Inc. (Nasdaq: PCVX), please note that in the first bullet under “Recent
Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
08:10pm, Wednesday, 12'th Aug 2020
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel va
Stocks To Watch: Postmates, Walgreens And Cannabis Plays
08:17am, Saturday, 04'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
08:05pm, Tuesday, 16'th Jun 2020
FOSTER CITY, Calif., June 16, 2020 -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines.
Vaccine maker Vaxcyte's shares soar 22% in trading debut
03:24pm, Friday, 12'th Jun 2020
Shares of Vaxcyte Inc. soared 22% in their trading debut Friday, after the company's IPO priced at the top end of its price range, and was upsized to 15.6 million shares from earlier plans to sell ju
Vaccine maker Vaxcyte upsizes IPO and prices at top end of range
10:18am, Friday, 12'th Jun 2020
Vaxcyte Inc. priced its initial public offering late Thursday at $16 a share, the top end of its price range, and upzied the deal to 15.6 million shares from earlier plans to sell just 14 million. Th
Vaxcyte Announces Pricing of Upsized Initial Public Offering
05:06am, Friday, 12'th Jun 2020
FOSTER CITY, Calif., June 11, 2020 -- Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to.
Vaxcyte Appoints Halley E. Gilbert to Board of Directors
12:30pm, Wednesday, 03'rd Jun 2020
FOSTER CITY, Calif., June 03, 2020 -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and.
SutroVax Announces Name Change to Vaxcyte
12:30pm, Thursday, 21'st May 2020
SutroVax, Inc., a next-generation vaccine company, today announced that it has changed its name to Vaxcyte, Inc. The new name more accurately reflects the Company’s mission to improve global health
